Company: AILIM
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001002910-25-000098
Chunk: 94

Company: Ameren Illinois Co
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 1
Chunk 94
---
 goals.For the three months ended March 31, 2025 and 2024, excess tax benefits (deficiencies) associated with the settlement of stock-based compensation awards decreased income tax expense by $1 million and increased income tax expense by $1 million, respectively.Deferred CompensationAt March 31, 2025, and December 31, 2024, the present value of benefits to be paid for deferred compensation obligations was $79 million and $79 million, respectively, which was primarily reflected in “Other deferred credits and liabilities” on Ameren’s consolidated balance sheet.Operating RevenuesAs of March 31, 2025 and 2024, our remaining performance obligations for contracts with a term greater than one year were immaterial. The Ameren Companies elected not to disclose the aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied as of the end of the reporting period for contracts with an initial expected term of one year or less.See Note 14 – Segment Information for disaggregated revenue information.Excise TaxesAmeren Missouri and Ameren Illinois collect from their customers excise taxes, including municipal and state excise taxes and gross receipts taxes that are levied on the sale or distribution of natural gas and electricity. The following table presents the excise taxes recorded on a gross basis in “Operating Revenues – Electric,” “Operating Revenues – Natural gas” and “Operating Expenses – Taxes other than income taxes” on the statements of income for the three months ended March 31, 2025 and 2024:Three Months20252024Ameren Missouri$38 $35 Ameren Illinois43 37 Ameren$81 $72 Earnings per ShareThe following table reconciles the basic weighted-average number of common shares outstanding to the diluted weighted-average number of common shares outstanding for the three months ended March 31, 2025 and 2024:Three Months20252024Weighted-average Common Shares Outstanding – Basic270.0 266.4 Assumed settlement of performance share units and restricted stock units1.0 0.4 Dilutive effect of forward sale agreements0.4 — Weighted-average Common Shares Outstanding – Diluted(a)271.4 266.8 (a)There was an immaterial number of anti-dilutive performance share units excluded from the earnings per diluted share calculations for the three months ended March 31, 2025 and